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Abstract
This study aims to assess the in vivo performance of cell–scaffold constructs composed of goat
marrow stromal cells (GBMCs) and SPCL (a blend of starch with polycaprolactone) fibre mesh
scaffolds at different stages of development, using an autologous model. GBMCs from iliac crests
were seeded onto SPCL scaffolds and in vitro cultured for 1 and 7 days in osteogenic medium. After
1 and 7 days, the constructs were characterized for proliferation and initial osteoblastic expression
by alkaline phosphatase (ALP) activity. Scanning electron microscopy analysis was performed to
investigate cellular morphology and adhesion to SPCL scaffolds. Non-critical defects (diameter 6 mm,
depth 3 mm) were drilled in the posterior femurs of four adult goats from which bone marrow and
serum had been collected previously. Drill defects alone and defects filled with scaffolds without cells
were used as controls. After implantation, intravital fluorescence markers, xylenol orange, calcein
green and tetracycline, were injected subcutaneously after 2, 4 and 6 weeks, respectively, for bone
formation and mineralization monitoring. Subsequently, samples were stained with Le´vai–Laczko´
for bone formation and histomorphometric analysis. GBMCs adhered and proliferated on SPCL
scaffolds and an initial differentiation into pre-osteoblasts was detected by an increasing level of
ALP activity with the culture time. In vivo experiments indicated that bone neoformation occurred
in all femoral defects. The results obtained provided important information about the performance
of SPCL–GBMC constructs in an orthotopic goat model that enabled future studies to be designed to
investigate in vivo the functionality of SPCL–GBMC constructs in more complex models, viz. critical
sized defects, and to evaluate the influence of in vitro cultured autologous cells in the healing and
bone regenerative process. Copyright  2010 John Wiley & Sons, Ltd.
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1. Introduction
Skeletal regeneration is initiated by a traumatic episode
involving bone damage that often includes the perios-
teum, bone marrow spaces and surrounding soft tissues.
Trauma such as fracture or surgical cutting and drilling
causes a physical disruption of the mineralized tissue
matrix, the death of many cell types and interruption of
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the local blood supply. A key stage in bone regenera-
tion is the differentiation of pluripotential mesenchymal
cells from the initial granuloma containing several cellular
types, towards cartilage, fibrous cartilage, fibrous tissue
or bone (Dennis et al., 2001).
Bone marrow mesenchymal cells (BMCs) have been
widely used in studies involving tissue-engineering (TE)
strategies for bone and cartilage, as they provide a
potential autologous source of cells (Mauney et al., 2005b;
Muraglia et al., 2000; Pittenger et al., 1999; Tuan et al.,
2003) that are able to differentiate into chondrogenic
and osteogenic lineages in the presence of specific
differentiation supplements, such as transforming growth
factor-β and dexamethasone, respectively (Oliveira et al.,
2006).
Although BMCs are abundant in skeletal tissues,
damaged bone may fail to heal spontaneously and, in
most cases, the use of marrow cells alone is not ideal
to accomplish the necessary requirements for the repair
of injured tissues. In order to overcome the limitations
of current treatments, the TE field proposes the use of
bioactive or inductive factors as well as a scaffold structure
to support and complement the role of reparative cells
(differentiated or non-differentiated) when implanted on
injured or dysfunctional areas.
The selection of a scaffold material for bone TE purposes
is therefore of extreme significance (Hutmacher et al.,
2007). Scaffolds must be biocompatible, biodegradable
and, simultaneously, promote the easy diffusion of
nutrients and cellular waste products, as well as present
suitable mechanical properties for cell support and
new tissue ingrowth. Furthermore, the scaffold must
possess adequate porosity, good interconnectivity and
a degradation rate (Gomes et al., 2004) adapted to the
time required for tissue regeneration.
Several biodegradable polymers have been proposed
to obtain three-dimensional (3D) scaffolds for bone TE,
including a new range of natural origin polymers based
on starch (Gomes et al., 2004, 2008; Mendes et al., 2001).
Starch-based polymers, such as starch–polycaprolactone
blends (SPCL), are degradable and biocompatible poly-
mers with distinct structural forms, which have been
shown to be suitable for bone TE applications in sev-
eral previous studies (Gomes et al., 2003, 2006a, 2006b;
Mendes et al., 2003; Santos et al., 2007).
The seeding and extended in vitro culture of cells
within a biodegradable scaffold before implantation is
a widespread TE approach. Some studies also report
the importance of a cell in vitro preculture period onto
scaffolds, as it may influence the osteogenic potential of
bone marrow cells (Sikavitsas et al., 2003). During the
in vitro culture, seeded cells are expected to proliferate
and secrete growth factors and matrix proteins that will
possibly stimulate other cells to accelerate or recover
and, in more dramatic situations, to stimulate the natural
regenerative functionality when transferred to the in vivo
environment.
Ultimately, and despite the relevance of results
achieved from in vitro studies, the use of animal models
is an essential step in evaluating TE constructs prior to
their clinical application. Different animal models, such
as rat, rabbit, dog, goat, sheep or monkey, have been
projected, with the purpose of fairly accurate human
model requests (Buma et al., 2004) and guiding potential
clinical applications.
In the last few years, goats have become increasingly
popular as a valid animal subject in this research field.
In fact, due to its nature of a higher-level vertebrate
and non-pet status when compared to dogs, goats play
a significant role in the orthopaedics field as a feasible
model for orthotopic applications. In addition, goats not
only have metabolic and bone remodelling rates similar to
that of humans but also a comparable sequence of events
in bone graft incorporation and healing capacities (Pearce
et al., 2007), which explains the fact that this model
has been frequently used in studies of bone formation
and regeneration (Kruyt et al., 2004; Li et al., 2006; Zhu
et al., 2006), biocompatibility (Mendes et al., 2001) and
osteochondral regeneration (Lane et al., 2004; Niederauer
et al., 2000).
Cell-based strategies sustained by a support material
have been applied to generate ectopic or orthotopic
bone (Giannoni et al., 2008; Kirker-Head et al., 2007;
Kruyt et al., 2007; Meinel et al., 2006). Although the
latter presents a major potential for skeletal regeneration
procedures, most in vivo studies are conducted using
an ectopic approach and/or performed in small animal
models, such as mice or rats (Kruyt et al., 2007; Livington
et al., 2002; Mauney et al., 2005a; Mastrogiacomo et al.,
2007; Mendes et al., 2003; Trojani et al., 2006). Although
non-critical sized defects are usually evaluated in ectopic
models, orthotopic location provides a more accurate
idea of the influence or local effects of implanted cells
or cell–scaffold constructs where they were initially
designed to be functional.
Autologous approaches have also been considered in
recent studies (Kruyt et al., 2004; Niederauer et al., 2000;
Zhu et al., 2006), avoiding immune complex problems
that interfere with the regenerative process as well as
with the patient follow-up.
The present manuscript describes the assessment of
the in vivo osteogenic ability of cell–scaffold constructs
based on seeding marrow stromal cells onto SPCL
fibre mesh scaffolds and in vitro cultured for different
periods of time using an autologous goat model. As
already mentioned, these scaffolds have demonstrated
a very good in vitro functionality in several studies
performed by our group. Therefore, the aim of this
work was to obtain the first data concerning the
in vivo functionality of SPCL scaffolds and goat bone
marrow cells (GBMCs) constructs in new bone formation
of a orthotopic non-critical defect, in order to better
understand the behaviour of cell–scaffold constructs
implanted in femurs and to design future in vivo studies
to be performed in the critical size defect model,
which will be the ultimate applications for such TE
strategies.
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2. Materials and methods
2.1. Production of SPCL scaffolds
The polymer scaffolds used in this study were based on
a blend of corn starch and ε-polycaprolactone (SPCL;
30% : 70% wt) and were produced by a fibre-bonding
method into mesh structures with a porosity of ∼75% and
cut into discs (diameter 6 mm, height 2 mm), as described
previously (Gomes et al., 2006a, 2006b). All samples were
sterilized using ethylene oxide and prior to cell seeding
the scaffolds were immersed in 20 ml serum-free medium
in 50 ml tubes for 30 min.
2.2. Animal study
Four skeletally adult female goats weighting 30–45 kg
were used in this study. The housing care and
experimental protocol were performed according to
the national guidelines after approval by the National
Ethical Committee for Laboratory Animals (2007-07-27;
document no. 018 939) and conducted in accordance
with international standards on animal welfare as defined
by the European Communities Council Directive of 2
November 1986 (86/609/EEC). During the entire study,
adequate measures were taken to minimize any pain and
discomfort. Animals were kept in light- and temperature-
controlled rooms and health parameters, such as appetite,
weight maintenance or signs of infection, were monitored
on a daily basis.
2.3. GBMCs harvesting and culture
In order to harvest the GBMCs, the animals were
placed under general anaesthesia and iliac regions were
shaved and disinfected. The animals were submitted to
a pre-anaesthetic medication with acepromazine maleate
(5 mg EV, Calmivet, Veto´quinol, France) and placed
under general anaesthesia by induction with thiopenthal
sodium (20–25 mg/kg EV, Pentothal sodium, Abbott
Laboratories, USA), maintained by inhalation of a mixture
of 1.5% isoflurane (IsoFlo, Abbott Laboratories) and
oxygen for a maximum of 30 min.
From each iliac crest of the goats, 10 ml samples of bone
marrow aspirate were obtained, using a bone marrow
aspiration needle (Inter.V, Medical Device Technologies
Inc., Denmark) and a 10 ml syringe containing 1 ml
heparin (5000 IU, heparin sodium, B. Braun Medical Inc.,
USA) to avoid marrow coagulation. The content of each
syringe was then transferred into sterile 50 ml tubes and
mixed with 30 ml RPMI-1640 culture medium (Sigma-
Aldrich, USA), containing 1% penicillin–streptomycin
(Gibco, USA) and an additional 1 ml heparin (5000
IU). Afterwards, GBMCs were centrifuged for 10 min
at 1200 rpm and a dense cellular pellet was collected
and cultured in 75 cm2 flasks (Corning, USA) using
basic culture medium (Dulbecco’s modified Eagle’s
medium – DMEM; Sigma-Aldrich, USA) supplemented
with 10% autologous serum isolated from goat peripheral
blood and 1% antibiotic/antimicotic solution (A/B,
Invitrogen, Spain). Four days after the harvesting
procedure, the medium containing non-adherent cells
was removed and the adherent cells were rinsed with a
sterile phosphate-buffered saline (PBS; Sigma) solution
and fresh medium was added. The cells were expanded
in basic culture medium until about 80% of confluence
before being seeded onto SPCL scaffolds at passage 3.
During this study, every 3 weeks, goat peripheral
blood samples were collected from the jugular vein
of each animal in order to obtain autologous serum,
and collected into serum tubes without anticoagulant
(Sarstedt, Monovette, Serum Gel S, Germany); 30 min
after collection the blood samples were centrifuged at
3000 rpm for 10 min. Harvested sera were immediately
stored in appropriate tubes and preserved at −20 ◦C
until use.
2.4. In vitro cell seeding and culture
In order to cell-seed the scaffolds, GBMCs were thawed
and expanded until 90% confluence. Afterwards, the
cells were enzymatically lifted with 0.05% trypsin–EDTA
(Invitrogen, Spain) and at passage 2 a cell suspension
was prepared (2.5 million cells/ml) and seeded onto
the SPCL porous scaffolds in a dropwise manner, at a
cellular density of 0.5 million cells/scaffold and using
seeding chambers in order to improve cell seeding
efficiency by avoiding cellular dispersion. After in vitro
seeding, cell–scaffold constructs were cultured in non-
adherent 12-well plates (Costar, Becton Dickinson, USA)
to avoid cellular adhesion to the bottom of the plates, and
using minimal essential medium Eagle’s α-modification
(α-MEM; Sigma-Aldrich), autologous sera (10%), A/B
(1%) and osteogenic supplements, viz. dexamethasone
(10−8 M; Sigma-Aldrich), ascorbic acid (50 µg/ml; Sigma)
and β-glycerophosphate (10 mM; Sigma) for 1 and 7 days
prior to implantation. An in vitro control of the experiment
was kept, consisting of cell–scaffold constructs seeded
and cultured under the same conditions and for the same
periods of time. Autologous culture medium was changed
twice a week in all cell cultures.
2.5. In vitro characterization of cell–scaffold
constructs
Samples were collected on days 1 and 7 after seeding for
the assessment of proliferation by DNA quantification and
initial osteogenic differentiation studies by ALP activity
analysis. For these purposes, samples removed from
culture were rinsed twice in a PBS solution and transferred
into 1.5 ml microtubes containing 1 ml ultra-pure water.
Then, GBMC–SPCL constructs were incubated for 1 h at
37 ◦C in a water-bath and stored in a −80 ◦C freezer,
promoting a thermal shock variation and thus inducing
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cell lysis. Before assessing DNA and ALP levels, constructs
were thawed and sonicated for 15 min.
A fluorimetric dsDNA quantification kit (PicoGreen,
Molecular Probes, USA) was used to determine the
proliferation of cells in GBMC–SPCL constructs. Samples
and standards (0–2 µg/ml) were prepared. Triplicates
were made for samples and standards. Afterwards,
the 96-well white plate (Costar; Becton-Dickinson) was
incubated for 10 min in the dark and the fluorescence
was read using a microplate ELISA reader (BioTek,
USA) at an excitation of 485/20 nm and an emission
of 528/20 nm. A standard curve was developed in
order to read DNA values of samples from the standard
graph.
ALP activity was measured to detect initial osteogenic
differentiation on days 1 and 7. For this purpose, to each
well of a 96-well plate (Costar; Becton-Dickinson) were
added 20 µl sample plus 60 µl substrate solution consist-
ing of 0.2% (wt/v) p-nytrophenyl phosphate (Sigma) in
a substrate buffer with 1 M diethanolamine HCl (Merck,
Germany), pH 9.8. The plate was then incubated in the
dark for 45 min at 37 ◦C. After the incubation period,
80 µl stop solution [2 M NaOH (Panreac, Spain) plus
0.2 mM EDTA (Sigma)] was added to each well. Stan-
dards were prepared with p-nytrophenol (10 µM/ml;
Sigma) in order to achieve final concentrations in the
range 0–0.3 µM/ml. Samples and standards were pre-
pared in triplicates. Absorbance was read at 405 nm
and sample concentrations were read from the standard
graph.
GBMCs adhesion and morphology was also investigated
using scanning electron microscopy (SEM) by previously
fixing cell–scaffold constructs in a 2.5% glutaraldehyde
solution (Sigma), rinsing and dehydrating through a series
of ethanol concentrations before sputter-coating them in
gold.
2.6. Implantation procedures
Surgical procedures were performed under standard
conditions and the drill-hole technique selected was based
on the one described by Hallfeldt et al. (1995). Animals
were submitted to the anaesthetics protocol described
in the previous section. After general anaesthesia, each
goat was positioned in lateral recumbency, prepared and
draped in a sterile manner to perform a surgical access
to the lateral diaphysis of the femur. A skin incision was
then performed from the greater trochanter and continued
distally to the lateral femoral condyle. The subcutaneous
tissue, tensor fascia lata and lateral fascia of the vastus
muscle were incised. The biceps femoris muscles were
retracted posteriorly, and the vastus muscle was retracted
anteriorly, after being detached from the linea aspera
and femora shaft, like the periosteum. Non-critical size
defects (diameter 6 mm, depth 3 mm) were drilled in
the lateral diaphysis of both posterior femurs of the four
adult goats with a bone drill (Synthes, Switzerland).
Eight drill holes were made in each posterior femur,
with a separation distance between drill holes of 3 cm,
in two non-parallel sections in order to avoid fracture
tension in the bone and also to avoid new bone
formation among the drill holes. Two of these were
left empty and two were filled with scaffolds without
cells, which were the controls for this experiment. The
remaining drill holes were filled in with cell–scaffold
constructs cultured for 1 day (two defects) and 7 days
(two defects). The implants were carefully press-fitted
and placed into the bilateral defects. The muscle was
replaced over the bone, and the fascia lata and skin
were closed with resorbable and non-resorbable sutures,
respectively.
After implantation, intravital fluorescence markers, viz.
xylenol orange (90 mg/kg; Sigma Aldrich), calcein green
(10 mg/kg; Sigma) and tetracycline (25 mg/kg; Sigma)
were injected subcutaneously (after 2, 4 and 6 weeks,
respectively) for bone formation and mineralization
monitoring, along with the implantation period.
The animals were observed in ambulation on a daily
basis and signs of infection or pain were monitored.
During the first postoperative week, the animals were
subjected to analgesic medication with flunixin meglumin
[1 mg/kg intramuscular (i.m.) each 24 h; Finadyne P.A.,
Schering-Plough II, USA] for 2 days and to antibiotic
therapy with amoxicillin (15 mg/kg i.m. each 24 h;
Clamoxyl L.A., Pfizer, USA) for 7 days.
After implantation, the animals were kept in a 25 m2
room, with freedom of movement and full weight-bearing
of the posterior limbs during the complete post-operative
period.
2.7. Harvesting samples after implantation
Six weeks after the implantation procedure and 24 h after
tetracycline injection, animal euthanasia was performed,
using an overdose of pentobarbital sodium (Eutasil,
Sanofi, France). The femurs were then removed and cut
into single defect-sections. The sections were fixed in
4% formaldehyde solution, pH 7.2 (Sigma), and embed-
ded in glycol methacrylate blocks (Technovit 7200,
VLC–Heraus Kulzer GmbH, Germany). Thin sections
of about 30 µm were prepared, using a special micro-
tome according to the Donath et al. (1995) technique,
using an Exakt-Cutting system (Aparatebau GMBH, Ger-
many) in order to slice the calcified bone. Only the
mid-section of each block was used for observation
using a fluorescence microscope (Olympus BX51, Ger-
many) and for histomorphometric analysis. Additional
sections were also stained with Le´vai–Laczko´ (Jeno and
Geza, 1975) to observe new bone formation, using a
stereo-microscope (Olympus SZX9, Germany). Quantita-
tive measurement for bone neoformation was carried out
after selecting relevant drill surrounding areas, where
neobone was marked and quantified using Microimage
4.0 software.
Copyright  2010 John Wiley & Sons, Ltd. J Tissue Eng Regen Med 2011; 5: 41–49.
DOI: 10.1002/term
SPCL scaffolds cultured with goat marrow cells; functionality in femoral defects 45
2.8. Statistical analysis
Statistical analysis was carried out by mean ± standard
error of mean (SEM), using t-Test and two-way ANOVA
for in vitro and for in vivo measurements, respectively. At
least four samples were considered in the in vitro assays
(DNA, ALP, SEM), while 16 samples were considered
in vivo for each condition; (a) empty drill hole; (b) drill
hole with SPCL scaffold; drill holes with SPCL seeded with
GBMCs for either (c) 1 day or (d) 7 days in osteogenic
medium.
In the present study, controls of the experiment were
considered indirectly by in vitro assessments of DNA
and ALP activity studies and directly by the histometric
analysis of induced drill holes made in the posterior
femurs of each animal.
3. Results and discussion
3.1. In vitro characterization of autologous
GBMC–SPCL constructs
SEM micrographs (Figure 1) indicated that GBMCs
attached to the SPCL fibre meshes presented a typical elon-
gated morphology and were homogeneously distributed
throughout the surface of the SPCL scaffold. These pic-
tures also showed an increase in GBMCs proliferation with
the culture time, as observed by the cell layer formed on
top of the fibres when compared to cells cultured for 1 day
under the same conditions.
Regarding cell proliferation results, data obtained
from the DNA content test (Figure 2) indicated that
proliferation of GBMCs seeded onto SPCL scaffolds
seemed to decrease slightly after 7 days in culture,
although no statistically differences were found (p < 0.05,
t-test) to support these results. Nevertheless, the tendency
to cell proliferation decrease could be directly associated
to the increment of ALP activity of GBMCs.
Results obtained from the ALP assay revealed that
after 7 days in culture with osteogenic medium there was
a significant increment in ALP activity levels (Figure 3;
Figure 2. In vitro double-stranded DNA concentration in SPCL
scaffolds seeded with GBMCs cultured in osteogenic culture for
1 and 7 days
p < 0.05, t-test) when compared to levels obtained for
1 day of culture, as expected, since these cells were
biochemically stimulated towards the osteogenic pathway
(Oliveira et al., 2006; Rodrigues et al., 2006, 2007).
3.2. In vivo studies
All animals completed the study. No weight differences
were observed and no signs of infection or inflammation
were found nearby the implantation areas after 6 weeks.
In this pilot study, orthotopic defects were drilled
to determine the influence of SPCL scaffolds alone
and osteogenic differentiation stage of GBMCs seeded
onto SPCL scaffolds in bone neoformation. In this way,
cells were cultured on SPCL scaffolds, after 1 day in
osteogenic culture, practically undifferentiated, or after
7 days in culture, when the cells had already initiated the
osteogenic process, as indicated by in vitro ALP activity
levels and by previous studies performed by our group.
Prior to construct characterizations, the femurs were
cleaned of muscle, as the induced drill holes were not
Figure 1. (A) SEM micrographs of SPCL scaffolds seeded with GBMCs and in vitro cultured in osteogenic culture for 1 day. (B) SEM
micrographs of SPCL scaffolds seeded with GBMCs and in vitro cultured in osteogenic culture for 7 days
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Figure 3. In vitro ALP activity in SPCL scaffolds seeded with
GBMCs cultured in osteogenic culture for 1 or 7 days
easily detected 6 weeks after implantation (both controls
and drills containing the cell–SPCL constructs) due to
an excellent regeneration process, which occurred in all
cases. In order to expose the drill holes and access the
inner region, the bone was longitudinally cut. Under
macroscopic observation of femoral defects, defects filled
with cell–SPCL constructs seemed to have higher bone
growth than empty drill defects or defects filled with SPCL
material alone.
3.3. Histological and fluorescence analysis
The observation of sections stained with Le´vai–Laczko´,
a specific neobone marker (Figure 4), shows that there
was bone formation in all drill defects, as expected in
non-critical defects. Nevertheless, there was an enhanced
neobone formation in defects containing SPCL scaffolds
seeded with GBMCs, which suggests the importance of
the presence of these cells in the constructs to stimulate
bone formation.
Giant cells were present in one of the studied samples,
which indicated that after 6 weeks scaffold materials are
being absorbed by the body, according to some research
works (Pego et al., 2003).
The sequential administration of fluorescent dyes
allowed bone ingrowth to be monitored during the overall
period of implantation.
Again, the presence of GBMCs seems to positively influ-
ence bone ingrowth with time, especially 2 weeks after
implantation, when calcein green was subcutaneously
injected (Figure 5).
However, the degradation rate of each staining was
faster than expected, probably because of the rapid
Figure 4. Drill sections marked with Le´vai–Laczko´ staining: (A) control 1, empty drill defects; (B) control 2, defects filled with SPCL
(no cells); (C) defects filled with cells–SPCL constructs after (C1) 1 day of culture and (C2) 7 days of culture in osteogenic medium
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Figure 5. Drill sections marked with xylenol orange (red), calcein green (green) and tetracycline (not observed) fluorescence
stainings: (A) control 1, empty drill defects; (B) control 2, defects filled with SPCL (no cells); (C) defects filled with cell–SPCL
constructs after (C1) 1 day of culture and (C2) 7 days of culture in osteogenic medium
metabolism of these animals. Due to this, in some
section regions, bone formation was dark just before
the subsequent fluorescent stain was injected. In some
pictures is still possible to observe dark neobone areas,
as the new bone was formed. As tetracycline dye was
injected just 24 h before the retrieval of the samples, the
fluorescence mark was too light to be easily observed in
the drill defect images. Even though the stain had reached
the bone drill holes, 24 h was probably an insufficient
period of time for the fluorescence to be imprinted in the
fresh bone.
Besides a qualitative analysis, histomorphological
parameters of bone neoformation were measured to
obtain quantitative data regarding the percentage of new
bone formation and new bone roundness. The percentage
of neobone present in each drill hole was compared
with the remaining drill holes and statistically analysed
(Figure 6).
The amount of new bone formation tended to increase
in the presence of cell-seeded scaffolds, although the
quantitative analysis performed did not reveal significant
differences between the values (%) measured for new
bone formation between defects with and without GBMCs.
Other parameters, viz. roundness of new bone
formation, were also considered in order to evaluate
the spreading of neobone tissue into the induced defects.
As can be observed in Figure 7, there was a tendency
to an increment in new bone roundness obtained in
Figure 6. New bone formation percentage in the different
induced drills: (A) empty drill defects; (B) defects filled with
SPCL (no cells); defects filled with cell–SPCL constructs after
(C) 1 day of culture and (D) 7 days of culture in osteogenic
medium
defects filled with cell-seeded scaffolds (with increasing
culture times) when compared to empty defects. This fact
may be associated with cellular stimulation provided by
autologous cells implanted in the animals.
Neither inflammatory response after 6 weeks of
implantation nor animal behaviour modifications in terms
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Figure 7. New bone roundness measured for the different
induced drills: (A) empty drill defects; (B) defects filled with
SPCL (no cells); defects filled with cell–SPCL constructs after
(C) 1 day of culture and (D) 7 days of culture in osteogenic
medium
of food intake, movement or general health were detected.
The presence of fibre mesh SPCL scaffolds allowed for
neobone ingrowth in the induced defects. Furthermore,
traces of cell-mediated absorption were observed in one
of the retrieved samples by the presence of fibrous
tissue containing an occasional multinucleated giant cell
on the implant surface. This may indicate that locally,
material absorption can initiate at an early stage of bone
regeneration.
4. Conclusions
In the present study it was possible to observe the
neoformation of bone in all orthotopic induced drill
holes in the goat femurs, as expected for non-critical
defects. Nevertheless, increased neobone formation was
found, as well as cellular distribution into the defect
where the SPCL–GBMCs constructs were implanted.
This increment was enhanced with the in vitro culture
time, which indicates that the in vitro culture time of
GBMCs onto the SPCL constructs may also play an
important role in new bone growth. The data obtained
concerning in vitro proliferation and differentiation of
these constructs suggest that the in vitro culture time
of GBMCs in osteogenic medium, although still at a
very early stage, is likely to play an important role in
bone growth onto these defects. However, further studies
should provide better understanding of the importance
of the number of cells and their differentiation stage, as
well as the time needed for osteogenic supplementation,
to induce significant changes in bone formation in vivo.
Nevertheless, SPCL fibre mesh scaffolds showed a great
potential for the development of adequate tissue 3D
support for the regeneration of bone in non-critical
defects. Thus, the results obtained provided important
information about the performance of SPCL–GBMC
constructs in an orthotopic goat model that enabled
future studies to be designed to investigate the in vivo
functionality of GBMC–SPCL constructs in more complex
models, viz. in induced critical sized defects, and to
evaluate the influence of in vitro cultured autologous cells
in the healing and bone regenerative process.
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